Histological characteristics of metastasizing thin melanomas: A case-control study of 43 cases

Archives of Dermatology

Volumn 138, Issue 5, 2002, Pages 603-608

  Guitart, Joan ^a   Lowe, Lori ^b   Piepkorn, Michael ^c   Prieto, Victor G ^d   Rabkin, Michael S ^e   Ronan, Salve G ^f   Shea, Christopher R ^g,k   Tron, Victor A ^h   White, Wain ⁱ   Barnhill, Raymond L ^j  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Rabkin Dermatopathology Laboratory   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^g DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ WAKE FOREST SCHOOL OF MEDICINE   (United States)

^j GEORGETOWN UNIVERSITY   (United States)

^k UNIVERSITY OF CHICAGO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HIGH RISK POPULATION; HISTOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; MALE; MELANOMA; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; THICKNESS; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR REGRESSION;

ADULT; AGED; CARCINOMA IN SITU; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; REMISSION, SPONTANEOUS; RISK FACTORS; SKIN NEOPLASMS;

EID: 0036578896     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Predicting 5-year outcome for patients with cutaneous melanoma in a population-based study
2. A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage 1) melanoma treated in Alabama, USA, and New South Wales, Australia
3. Thin malignant melanomas (<1.5 mm) with metastasis: A histological study and survival analysis
4. Patients presenting with thin melanomas (<0.76 mm thick) who subsequently have a poor prognosis by development of metastases
5. The metastasizing thin cutaneous melanoma: Case report
6. Thin regressing malignant melanoma: Significance of concurrent regional lymph node metastases
7. Lethal "thin" malignant melanoma: Identifying patients at risk
8. Metastasis of a thin regressing malignant melanoma
9. Metastasis and death in patients with thin melanomas (<0.76 mm)
10. Biologic behavior of thin malignant melanomas with regressive changes
11. Metastases of thin melanomas
12. The regressing thin malignant melanoma: A distinctive lesion with metastatic potential
13. Histopathology and precursor lesions
14. A nationwide survey of observer variation in the diagnosis of thin cutaneous malignant melanoma including the MIN terminology
15. The thin malignant melanoma: Changing patterns of epidemiology and treatment
16. Prognostic factors in thin cutaneous malignant melanoma
17. Stereologic estimation of volume-weighted mean nuclear volume as a predictor of prognosis in "thin" malignant melanoma
18. Recurrence potential of thin primary melanomas
19. Prognostic factors for melanoma patients with lesions 0.76-1.69 mm in thickness: An appraisal of "thin" level IV lesions
20. Local recurrence and metastasis of thin malignant melanomas (≤1mm)
21. A study of thin (< 1.5 mm) malignant melanomas with poor prognosis
22. Histopathologic study of recurrent Clark level II melanomas
23. Histological regression in primary cutaneous melanoma: Recognition, prevalence and significance
24. Clinical features of superficial spreading melanomas with zones of regression
25. The prognostic significance of histologic regression in cutaneous melanoma
26. "Thin" malignant melanoma: Risk factors and clinical management
27. Cutaneous melanomas exhibiting unusual biologic behavior
28. Thin malignant melanomas with regression and metastases
29. Prognosis in patients with thin malignant melanoma: Influence of regression
30. Partial regression in thin primary cutaneous malignant melanomas clinical stage I: A study of 486 cases
31. Regression in malignant melanoma: A histologic feature without independent prognostic significance
32. Regression in thin malignant melanoma: Microscopic diagnosis and prognostic importance
33. Experience of thin cutaneous melanomas (less than 0.76 mm and less than 0.85 mm thick) in a large plastic surgery unit: A 5 to 17 year follow-up
34. Clinicopathological features of relapsing very thin melanoma
35. Identification of vertical growth phase in malignant melanoma: A study of interobserver agreement
36. The evaluation of diagnostic and prognostic criteria and the terminology of thin cutaneous malignant melanoma by the CRC Melanoma Pathology Panel
37. Thin (≤1 mm) melanomas of the extremities are biologically favorable lesions not influenced by regression
38. Prognostic significance of the patient's sex, tumor site, and mitotic rate in thin (≤1.5 mm) melanoma
39. Prognosis of thin cutaneous head and neck melanoma (<1 mm)
40. Thin melanomas with unusual aggressive behavior: A report on nine cases
41. Thin malignant melanomas of the head and neck
42. Influence of level and thickness on recurrence rate in thin melanomas
43. Prognostic significance of MIB-1 proliferative activity in thin melanomas and immunohistochemical analysis of MIB-1 proliferative activity in melanocytic tumors
44. Prognostic significance of p53 overexpression in thin melanomas
45. Morphometric, DNA and PCNA in thin malignant melanomas
46. Immunohistochemical assessment of tumor vascularity in recurrent Clark II melanomas using antibody to type IV collagen
47. Regressing thin cutaneous malignant melanomas (≤1.0 mm) are associated with angiogenesis